Invention Grant
US09050341B2 Methods of treating drug resistant and other tumors by administering 6,7-dialkoxy quinazoline derivatives
有权
通过施用6,7-二烷氧基喹唑啉衍生物治疗耐药性和其它肿瘤的方法
- Patent Title: Methods of treating drug resistant and other tumors by administering 6,7-dialkoxy quinazoline derivatives
- Patent Title (中): 通过施用6,7-二烷氧基喹唑啉衍生物治疗耐药性和其它肿瘤的方法
-
Application No.: US12833733Application Date: 2010-07-09
-
Publication No.: US09050341B2Publication Date: 2015-06-09
- Inventor: Bhujanga rao Abidhatla Kali Satya , Ramanadham Jyothi Prasad , Bollepalli Nageshwara Rao , Nannapaneni Venkaiah Chowdary
- Applicant: Bhujanga rao Abidhatla Kali Satya , Ramanadham Jyothi Prasad , Bollepalli Nageshwara Rao , Nannapaneni Venkaiah Chowdary
- Applicant Address: IN Hyderabad, Andhra Pradesh
- Assignee: NATCO PHARMA LIMITED
- Current Assignee: NATCO PHARMA LIMITED
- Current Assignee Address: IN Hyderabad, Andhra Pradesh
- Agency: Merchant & Gould P.C.
- Main IPC: A61K31/535
- IPC: A61K31/535 ; A61K31/497 ; A61K31/517

Abstract:
Methods employing and uses of a compound of formula (I) in inhibiting the growth of a tumor cell in a subject in need thereof. Methods employing and uses of a compound of formula (I) in treating pancreatic cancer in a subject in need of treatment for pancreatic cancer. Methods employing and uses of a compound of formula (I) in treating HER-2 positive breast cancer in a subject in need of treatment for HER-2 positive breast cancer. Methods employing and uses of a compound of formula (I) in treating drug resistant non-small cell lung cancer in a subject in need of treatment for drug resistant non-small cell lung cancer. Each of these methods can include administering to the subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof.Method of manufacturing a medicament including a compound of formula (I) for treating a subject suffering from growth of a tumor cell; for treating a subject suffering from pancreatic cancer; for treating a subject suffering from HER-2 positive breast cancer; or for treating a subject suffering from drug resistant non-small cell lung cancer.
Public/Granted literature
Information query